MATTHEW NELSON, BCBA
Behavior Analysts in San Marcos, CA
License number
California 1-14-16000
Category
Behavior Analysts
Type
Behavior Analyst
Address
Address
1972 Nortstar Way #163, San Marcos, CA 92078
Phone
(760) 802-7846
Professional information
Methods For Identifying Subjects At Risk Of Melanoma And Treatments Thereof
US Patent:
2005027, Dec 15, 2005
Filed:
Sep 11, 2003
Appl. No.:
10/661966
Inventors:
Richard Roth - La Jolla CA, US
Matthew Nelson - San Marcos CA, US
Andreas Braun - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Andreas Braun - San Diego CA, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Provided herein are methods for identifying risk of melanoma in a subject, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, and therapeutic methods for treating melanoma in a subject. These embodiments are based upon an analysis of polymorphic variations in a BRAF nucleic acid, which has a nucleotide sequence exemplified by SEQ ID NO:1.
Methods For Identifying Risk Of Breast Cancer And Treatments Thereof
US Patent:
2005027, Dec 8, 2005
Filed:
May 27, 2004
Appl. No.:
10/857780
Inventors:
Richard Roth - La Jolla CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
Methods For Identifying Risk Of Breast Cancer And Treatments Thereof
US Patent:
2009025, Oct 15, 2009
Filed:
May 27, 2004
Appl. No.:
11/570427
Inventors:
Richard B. Roth - San Diego CA, US
Matthew Roberts Nelson - San Marcos CA, US
Andreas Braun - San Diego CA, US
Stefan M. Kammerer - San Diego CA, US
Mikhail F. Denissenko - Poway CA, US
Rikard Reneland - Knivsta, SE
Caridad Rosette - San Diego CA, US
Matthew Roberts Nelson - San Marcos CA, US
Andreas Braun - San Diego CA, US
Stefan M. Kammerer - San Diego CA, US
Mikhail F. Denissenko - Poway CA, US
Rikard Reneland - Knivsta, SE
Caridad Rosette - San Diego CA, US
Assignee:
SEQUENOM, INC. - San Diego CA
International Classification:
C12Q 1/68, C07H 21/00, C40B 40/06, C07K 2/00
US Classification:
435 6, 536 231, 506 16, 530300
Abstract:
Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
Methods For Identifying Risk Of Breast Cancer And Treatments Thereof
US Patent:
2005021, Sep 29, 2005
Filed:
Nov 25, 2003
Appl. No.:
10/722939
Inventors:
Richard Roth - La Jolla CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
Methods For Identifying Risk Of Melanoma And Treatments Thereof
US Patent:
2005017, Aug 4, 2005
Filed:
Nov 6, 2003
Appl. No.:
10/704513
Inventors:
Richard Roth - La Jolla CA, US
Matthew Nelson - San Marcos CA, US
Stefan Kammerer - San Diego CA, US
Andreas Braun - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Stefan Kammerer - San Diego CA, US
Andreas Braun - San Diego CA, US
International Classification:
C12N005/06
US Classification:
435344100
Abstract:
Provided herein are methods for identifying risk of melanoma in a subject and/or subjects at risk of melanoma, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, therapeutic methods for treating melanoma in a subject and compositions comprising one or more melanoma cells and one or more CDK10, FPGT, PCLO or REPS2 directed agents. These embodiments are based upon an analysis of polymorphic variations in a CDK10, FPGT, PCLO or REPS2 nucleic acid, exemplified by nucleotide sequences of SEQ ID NO: 1, 2, 3 or 4.
Methods For Identifying Risk Of Breast Cancer And Treatments Thereof
US Patent:
2006020, Sep 14, 2006
Filed:
Nov 25, 2003
Appl. No.:
10/723683
Inventors:
Richard Roth - La Jolla CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
International Classification:
C12Q 1/68, A61K 48/00, C07H 21/04
US Classification:
435006000, 536024300, 514044000
Abstract:
Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
Methods For Identifying Risk Of Breast Cancer And Treatments Thereof
US Patent:
2005011, Jun 2, 2005
Filed:
Nov 25, 2003
Appl. No.:
10/723670
Inventors:
Richard Roth - La Jolla CA, US
Caridad Rosette - San Diego CA, US
Mikhail Denissenko - Poway CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Caridad Rosette - San Diego CA, US
Mikhail Denissenko - Poway CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
International Classification:
C12Q001/68, A61K048/00
US Classification:
435006000, 514044000
Abstract:
Provided herein are methods for identifying a risk of cancer in a subject and/or a subject at risk of cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating cancer, and therapeutic methods for treating cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in a KLF12 nucleic acid, which has a nucleotide sequence exemplified in SEQ ID NO: 1, 2 or 3.
Methods For Identifying Risk Of Melanoma And Treatments Thereof
US Patent:
2005011, Jun 2, 2005
Filed:
Nov 6, 2003
Appl. No.:
10/703817
Inventors:
Richard Roth - La Jolla CA, US
Matthew Nelson - San Marcos CA, US
Stefan Kammerer - San Diego CA, US
Andreas Braun - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Stefan Kammerer - San Diego CA, US
Andreas Braun - San Diego CA, US
International Classification:
C12Q001/68, A61K038/16, A61K048/00, A61K033/24, A61K031/4745
US Classification:
424059000, 514044000, 435006000, 514008000, 514283000, 424649000
Abstract:
Provided herein are methods for identifying risk of melanoma in a subject and/or subjects at risk of melanoma, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, therapeutic methods for treating melanoma in a subject and compositions comprising one or more melanoma cells and one or more NRP1, NID2 or ENDO180 directed agents. These embodiments are based upon an analysis of polymorphic variations in a NRP1, NID2 or ENDO180 nucleic acid, exemplified by nucleotide sequences of SEQ ID NO: 1, 2 or 3.
Methods For Identifying Risk Of Breast Cancer And Treatments Thereof
US Patent:
2005006, Mar 24, 2005
Filed:
Nov 25, 2003
Appl. No.:
10/723518
Inventors:
Richard Roth - La Jolla CA, US
Josephine Atienza - La Jolla CA, US
Mikhail Denissenko - Poway CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
Josephine Atienza - La Jolla CA, US
Mikhail Denissenko - Poway CA, US
Andreas Braun - San Diego CA, US
Stefan Kammerer - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Rikard Reneland - San Diego CA, US
International Classification:
C12Q001/68, G01N033/574
US Classification:
435006000, 435007230
Abstract:
Provided herein are methods for identifying a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
Methods For Identifying Risk Of Melanoma And Treatments Thereof
US Patent:
2005006, Mar 24, 2005
Filed:
Nov 6, 2003
Appl. No.:
10/703789
Inventors:
Richard Roth - La Jolla CA, US
Matthew Nelson - San Marcos CA, US
Stefan Kammerer - San Diego CA, US
Andreas Braun - San Diego CA, US
Matthew Nelson - San Marcos CA, US
Stefan Kammerer - San Diego CA, US
Andreas Braun - San Diego CA, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Provided herein are methods for identifying a subject at risk of melanoma and risk of melanoma in a subject, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, and therapeutic methods for treating melanoma in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.